The Uab Research Foundation

Aegis Therapeutics, LLC

Dennis J Pillion

Elias Meezan

Edward T Maggio

Sarah L Morgan

Joe Baggott

De-Chu C Tang

Chun-Ming Huang

Elis Meezan

John Jefferson Arnold

The present invention provides stable, self-assembling, biocompatible and biodegradable hydrogel formulations, into which one or more compounds may be incorporated allowing for delayed release or controlled release of the incorporated compounds as the hydrogel is degraded in the body.

Controlled release formulations

Described herein are methods for the noninvasive immunization of a subject that involve alkyl glycosides. Also described herein are compositions, kits, and devices for the noninvasive immunization of a subject.

Alkyl-glycoside enhanced vaccination

The present invention relates to a method of increasing the absorption of a compound via the ocular, nasal, nasolacrimal or inhalation route into the circulatory system of a patient. In particular, a method comprising administering with the compound an absorption enhancer comprising a nontoxic, nonionic alkyl glycoside is provided. Additionally provided are methods of raising or lowering the blood glucose level by administering glucagon or insulin, respectively, with such absorption enhancers. Finally, compositions for raising or lowering the blood glucose level are provided.

Absorption enhancers for drug administration

Growing community of inventors

Hoover, AL, United States of America

Dennis J Pillion